TEVA - Teva Pharmaceut Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TVIX (%) SPY (0.08%) SPLK (%) VXX (%) AAPL (%) SPX (0.08%) TQQQ (%) ZS (%) SPOT (%) QQQ (%) PNC (0.78%) PINS (-2.04%) PG (0.16%) PFE (0.29%) PANW (0.25%) NVS (-0.93%) MRK (-0.19%) MELI (%) MCD (-0.88%) IWM (%) GSK (%) GOOGL (%) GE (%) FB (%) EKSO (-2.32%)

Recommendation

Service : Alpha Swing Trades | Trader : Jonathan | Trade Date : 08/08/18

$TEVA - Teva Pharmaceutical Industries Limited

Buy Long

Trade

9.89 %

Target

$22.75

Issue Price

$25.00

Target Price

08/08/19

Target Date

$21.30

Stop Loss

Trade Closed - WINNER

Closed Position

Reason

11.16 %

P/L %

$25.29

Close Price

11

Days Held

08/20/18

Closed Date

To view trade details and get more recommendations from this trader Follow

5% or more up

TEVA - Teva Pharmaceutical ...

$7.37 -0.08[%]

15 mins delayed data

People also watch :

+Watchlist

17 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$7.45	Open	$7.48
Volume	9.16M	Market Cap	9.657B
Yield		Last Dividend

Day

52 Week

BeiGene's NDA for Zanubrutinib Gets ...	8:08 AM
The FDA grants priority review to BeiGene's (BGNE) NDA seeking approval for zanubrutinib as a treatment for mantle cell lymphoma.

Mallinckrodt (MNK) Stock Down 70.8% YTD ...	4:42 AM
Mallinckrodt (MNK) crashes 70.8% in the year so far due to various lawsuits and litigations.

Opioid Epidemic: Will Pharmas Scramble T...	08/21/19
Endo International and Allergan could avoid going to trial in a landmark case out of Ohio accusing pharmaceutical companies of marketing practices tha...

Endo Up on Settlement of a Few Cases Rel...	08/21/19
Endo (ENDP) finally has some good news for investors with the settlement of a few cases in Ohio related to opioid medications.

Oklahoma judge to rule on Monday in opio...	08/21/19
An Oklahoma judge will rule on Monday on whether Johnson & Johnson should be held liable in a lawsuit by the state's attorney general who argues the d...

Teva Launches Generic Version of Mylan&#...	08/21/19
Teva (TEVA) launches generic version of Mylan's (MYL) popular EpiPen Jr allergy treatment at a price of $300 for a pack of two.

Shares of Teva up 3% on positive migrain...	08/21/19
Shares of Teva Pharmaceutical Industries rose 3% in premarket trade Wednesday after The Lancet published results from a late-stage study showing that...

3 Warren Buffett Stocks to Buy Right Now	08/21/19
These three stocks from Berkshire Hathaway’s portfolio are too cheap to ignore.

Fremanezumab Data in The Lancet Demonstr...	08/21/19
The FOCUS study looked at patients who previously experienced inadequate response to two to four migraine preventive medication classes. Treatment wi...

Teva Rises on Positive Test Results for ...	08/21/19
Teva says patients taking Ajovy experienced a significant reduction in migraine days compared to those receiving placebos.

CLASS ACTION UPDATE for VNTR, TEVA and N...	08/20/19
NEW YORK, NY / ACCESSWIRE / August 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of t...

ANALYST RATINGS

13 analyst ratings (Last 6 months)

53.85 %

Strong Buy + Buy

Price Target (PT)

Buy rating	08/09/19
BMO Capital maintains Market Perform rating and lowers Price Target from $11.00 to $9.00

Sell rating	07/15/19
Morgan Stanley downgrades from Equal-Weight to Underweight rating and lowers Price Target from $16.00 to $6.00

Sell rating	06/11/19
Barclays initiates coverage with Underweight rating and announces Price Target of $8.00

Strong Buy rating	06/03/19
Oppenheimer upgrades from Perform to Outperform rating and announces Price Target of $12.00

Underperform rating	05/30/19
Bank of America downgrades from Buy to Underperform rating and lowers Price Target from $19.00 to $9.00

Hold rating	05/28/19
UBS downgrades from Buy to Neutral rating and lowers Price Target from $22.00 to $12.00

Buy rating	05/09/19
Wells Fargo maintains Market Perform rating and lowers Price Target from $18.00 to $17.00

Buy rating	04/11/19
Citigroup maintains Buy rating and lowers Price Target from $27.00 to $23.00

Buy rating	04/03/19
Wells Fargo maintains Market Perform rating and lowers Price Target from $20.00 to $18.00

Buy rating	03/28/19
BMO Capital initiates coverage with Market Perform rating and announces Price Target of $18.00

Hold rating	03/20/19
SunTrust Robinson Humphrey initiates coverage with Hold rating and announces Price Target of $17.00

Buy rating	03/07/19
and announces Price Target of $22.00

Hold rating	03/06/19
Morgan Stanley downgrades from Overweight to Equal-Weight rating and announces Price Target of $17.00

EARNINGS

Date	2019-08-07 (BMO)	Est. (EPS/Rev.)	$0.57/ 4.25B
Actual (EPS/Rev.)	$0.60/ $4.34 B	EPS (TTM)	0

TRADERS TRACKING $TEVA

Service Name	Trader	% Success
Equity and Teens	Equity and Teens	100.00 %	Follow
Trading	Trading	99.00 %	Follow
Swing for the fences	Gino Baldassano	78.00 %	Follow
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
smashingdon	Paul	70.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.